Rheumatology

Latest News

rheumatoid arthritis | Image credit: Evrymmnt.jpeg - stock.adobe.com
Etanercept Biosimilar Switch Shows Stable Outcomes and Disease Control in RA

May 13th 2025

Patients with rheumatoid arthritis (RA) who switched from Enbrel (reference etanercept) to a biosimilar maintained remission, even after their dose was reduced, with no signs of worsening based on clinical scores, ultrasound scans, or lab tests, according to a new study.

pharmaceutical sales data | Image credit: N F/peopleimages.com - stock.adobe.com
Samsung Bioepis Report Signals Turning Point for US Biosimilars

May 1st 2025

patient talking to doctor |  Image credit: New Africa - stock.adobe.com
Clinical Evidence Shows No Safety Gaps Between Biosimilar, Reference Adalimumab

April 26th 2025

eye on pharma banner
Eye on Pharma: Sandoz Files Antitrust Suit; Yuflyma Interchangeability; Costco’s Ustekinumab Pick

April 22nd 2025

Video Series
Video Interviews
Podcasts
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcas
CFB podcast banner
CFB podcast banner
cfb podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.